These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1008988)

  • 41. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
    Lampert F; Nitzschke U; Zwergel T
    Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.
    Dickinson JP; Caspary EA; Field EJ
    Br J Cancer; 1973 Feb; 27(2):99-105. PubMed ID: 4735112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test.
    Pasternak L; Jenssen HL; Köhler H; Pasternak G
    Eur J Cancer (1965); 1976 May; 12(5):389-93. PubMed ID: 954796
    [No Abstract]   [Full Text] [Related]  

  • 46. [Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases].
    Mross K; Mross B; Wolfrum DI
    Onkologie; 1982 Jun; 5(3):130-4. PubMed ID: 6181442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
    Hoffmann W; Werner W; Steiner R; Kaufmann R
    Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-mediated immunity to human myelin basic protein in schizophrenic patients.
    Kuritzky A; Livni E; Munitz H; Englander T; Tyano S; Wijsenbeek H; Joshua H; Kott E
    J Neurol Sci; 1976 Dec; 30(2-3):369-73. PubMed ID: 1003251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: Macrophage electrophoretic mobility test.
    Field EJ
    Lancet; 1976 May; 1(7969):1125-6. PubMed ID: 57527
    [No Abstract]   [Full Text] [Related]  

  • 51. A contribution to immunological tumour diagnostics in urology.
    Günther M; Friedrich A; Erdmann T; Jenssen HL; Werner H; Seyfarth M; Köhler H
    Int Urol Nephrol; 1978; 10(2):111-5. PubMed ID: 81191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
    Flavell DJ; Potter CW
    Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis.
    McDermott JR; Field EJ; Caspary EA
    J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):282-7. PubMed ID: 4133588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
    Nĕmecková S; Bubeník J; Indrová M
    Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The macrophage electrophoresis mobility (MEM) test for detection of cell sensitivity: technical analyses. I. Guinea pig peritoneal cells as indicator cells in the MEM test].
    Gryschek G; Schlott B; Strecker K
    Acta Biol Med Ger; 1982; 41(9):837-46. PubMed ID: 7164703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
    Malkovský M; Bubeník J; Holán V; Hasek M
    Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
    Nitzschke U; Zwergel T; Lampert F
    Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs.
    Flavell DJ; Goepel J; Wilson AP; Potter CW
    Br J Cancer; 1979 Sep; 40(3):424-36. PubMed ID: 92328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid development of a cancer-like antigen in normal tissue in vitro.
    Field EJ; Hughes D; Caspary EA
    Br J Cancer; 1973 Jun; 27(6):427-33. PubMed ID: 4737227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.